The Nasdaq Composite, NYSE, and NYSE American indices tracked the most actively traded stocks on January 22, 2026, reflecting heightened trading volumes across major U.S. exchanges. Market activity was driven by sector-specific momentum and earnings-related movements, with technology and financial stocks leading volume metrics.

Nasdaq’s most active shares included NVDA, AAPL, and MSFT, all registering significant trading volumes amid continued investor interest in semiconductor and cloud computing trends. On the NYSE, JPM and V, along with industrial names like CAT, saw elevated turnover, supported by macroeconomic data releases. NYSE American highlighted smaller-cap equities such as FSLR and AER, which gained traction due to niche market developments and speculative positioning. Trading volumes surged across all three venues, with total exchange activity surpassing average daily levels by 15%. The session concluded at 15:30 UTC, with no immediate regulatory interventions reported.

The U.S. gross domestic product expanded at an annualized rate of 4.4% in the third quarter of 2025, according to the Bureau of Economic Analysis, slightly above the previously reported 4.3% estimate. The revised figure reflects stronger consumer spending and business investment, reinforcing expectations of resilient economic momentum ahead of the year-end.

Consumption rose 4.1%, driven by durable goods and services, while nonresidential fixed investment increased 6.7%. Government spending contributed modestly, and exports edged up 0.8% as import growth slowed. The data, released on January 22, 2026, supports the Federal Reserve’s stance on maintaining current interest rates amid persistent inflation pressures. Markets reacted with muted volatility, with the S&P 500 gaining 0.3% in early trading. Analysts note that the strong GDP print may influence policy decisions in February, particularly if inflation data remains elevated.

60 Degrees Pharma Inc. (NASDAQ: SIXT) announced a strategic partnership with Runway Health on January 22, 2026, to broaden access to its investigational drug ARAKODA for patients with advanced solid tumors. The collaboration aims to integrate ARAKODA into Runway Health’s digital health platform, enhancing patient eligibility screening and clinical trial participation. Following the announcement, 60 Degrees Pharma’s stock surged 18.7% in after-hours trading, closing at $12.45 per share.

The partnership leverages Runway Health’s AI-driven oncology solutions to streamline patient identification and recruitment for ongoing Phase 2 trials of ARAKODA. The drug, an oral small molecule inhibitor targeting the PI3K pathway, has demonstrated preliminary efficacy in early-stage studies. The alliance marks a key step in 60 Degrees Pharma’s strategy to accelerate commercial readiness ahead of anticipated regulatory filings in 2027. Runway Health will provide data analytics and telehealth support to improve trial efficiency and patient outcomes.

Neurophos, a photonics startup based in Austin, raised $110 million in a Series A round led by Gates Frontier, with participation from Microsoft’s M12, Aramco Ventures, and others, to develop optical processing units (OPUs) for AI inferencing. The company aims to address rising power demands in AI data centers by using metasurface modulators—optical components 10,000 times smaller than traditional transistors—to perform matrix operations more efficiently than silicon-based GPUs.

Neurophos claims its OPU can achieve 235 Peta Operations per Second (POPS) at 675 watts, outperforming Nvidia’s B200 GPU, which delivers 9 POPS at 1,000 watts. The technology leverages photonic computing, where light enables faster, cooler computation, reducing energy use during inferencing. The startup says its chips can be manufactured using standard silicon foundry processes, easing scalability. Neurophos plans to launch its first chips by mid-2028 and is expanding engineering teams in San Francisco and Austin. Microsoft has expressed strong interest, citing the need for compute breakthroughs to match AI model advances.

Mistral CEO Arthur Mensch said on January 22, 2026, that claims of China’s AI lagging behind the West are “fairy tales,” citing China’s growing open-source capabilities as a challenge to U.S. tech leadership. His remarks contrast with views from DeepMind’s Demis Hassabis and Anthropic’s Dario Amodei, who argue China trails by about six months in frontier model development and is hindered by U.S. export restrictions.

Mensch made the comments during an interview at the World Economic Forum in Davos, highlighting the rise of Chinese AI startups like DeepSeek, whose R1 model sparked concern in Silicon Valley. Mistral, backed by a 13 million euro investment from ASML, is targeting enterprise clients including HSBC and BNP Paribas, aiming for over $1 billion in revenue this year and $1 billion in capital expenditures. The company is also actively exploring acquisition opportunities amid a global surge in AI infrastructure spending, with Nvidia CEO Jensen Huang estimating trillions of dollars will be invested in the sector.

The Federal Reserve's preferred inflation measure, the Personal Consumption Expenditures (PCE) price index, increased in November 2025 as consumer spending rose. The core PCE index, excluding food and energy, climbed 0.3% month-over-month, up from 0.2% in October, according to data released January 22, 2026. Year-over-year, core PCE inflation accelerated to 2.8%, slightly above the Fed’s 2% target.

The rise was driven by higher prices in services, particularly healthcare and housing, while goods inflation remained modest. Total personal consumption expenditures grew 0.4% in November, reflecting continued strength in household spending. The data suggest persistent inflationary pressures despite recent rate cuts, potentially complicating the Fed’s policy outlook. Markets reacted with muted volatility, with Treasury yields holding steady near 4.1%. The report adds pressure on policymakers to balance growth support with inflation control.

The Bank of Canada's exchange rate for the Canadian dollar against the U.S. dollar was reported at 10:00 a.m. Eastern Time on Thursday, January 22, 2026. The CAD/USD rate stood at 0.7540, reflecting a slight depreciation from the previous day’s close of 0.7552. Market participants are monitoring inflation data and central bank policy signals ahead of the Bank of Canada’s next interest rate decision scheduled for February 1.

The U.S. dollar strengthened slightly across major currencies amid expectations of a pause in Federal Reserve rate cuts. The U.S. dollar index rose to 103.85, up from 103.68 the prior session. Canadian bond yields edged higher, with the 10-year yield closing at 4.21%, as investors priced in tighter monetary conditions. The Canadian dollar remains under pressure from stronger-than-expected U.S. employment figures released earlier this week.

ACNB Corp. (ACNB) reported fourth-quarter earnings of $10.8 million, or $1.04 per share, on Jan. 22, 2026, surpassing analyst expectations of $1.26 per share. Adjusted earnings, excluding non-recurring and merger-related costs, were $1.35 per share.

Revenue totaled $47.2 million, with net interest income of $37.2 million, below the Zacks consensus forecast of $40.1 million. For the full year, ACNB posted net income of $37.1 million, or $3.60 per share, on revenue of $151.7 million. Shares have gained 5% year-to-date and 28% over the past 12 months.

Preferred Bank (PFIB) reported a rise in net income for the fourth quarter of 2025, driven by higher interest income and improved loan performance. The bank posted net income of $31.8 million, up from $27.6 million in the same period last year, reflecting a 15.2% year-over-year increase.

The results were supported by a 9.4% growth in total interest income to $145.2 million, fueled by rising rates and a larger earning asset base. Non-interest expenses rose modestly to $58.4 million, up 3.7% from $56.3 million in Q4 2024. Loan loss provisions declined to $1.2 million from $2.8 million, indicating stronger credit quality. Total assets stood at $10.2 billion as of December 31, 2025, an increase from $9.8 billion a year earlier. Preferred Bank's return on average assets reached 0.31%, compared to 0.28% in Q4 2024. The bank’s shares traded up 2.1% following the earnings release on January 22, 2026.

U.S. equities are positioned for additional gains following a de-escalation in geopolitical tensions involving Greenland, with investors shifting focus back to corporate earnings and monetary policy expectations. The S&P 500 rose 0.8% on January 22, 2026, while the Nasdaq Composite added 1.1%, driven by relief over reduced regional instability.

The easing of diplomatic friction between Denmark and the U.S. over military access in Greenland has alleviated concerns about supply chain disruptions and Arctic strategic risks. Analysts note that market volatility declined sharply, with the CBOE Volatility Index (VIX) dropping to 14.3 from 18.7 last week. Major indices remain near all-time highs, supported by strong Q4 earnings reports and expectations of a dovish Federal Reserve stance through mid-2026. Tech and industrial stocks led the rally, with Apple (AAPL) up 1.3% and Boeing (BA) gaining 2.1%. Investors are now watching upcoming Fed minutes and inflation data scheduled for release on January 24, 2026.

Plus Therapeutics Inc. announced key 2026 milestones for its REYOBIQ clinical development program and the commercial rollout of CNSide, a targeted therapy for central nervous system (CNS) cancers, on January 22, 2026. The company outlined plans to complete Phase 3 trials for REYOBIQ by mid-2026, with regulatory submission expected in the fourth quarter of the year.

The clinical program will focus on demonstrating efficacy and safety in patients with recurrent glioblastoma. Concurrently, Plus Therapeutics intends to launch CNSide in the U.S. market by December 2026, pending FDA approval. The company reported that CNSide has shown promising response rates in early-phase trials, with an overall response rate of 42% in a Phase 2 study. Financial details were not disclosed, but the company expects significant revenue potential from CNSide’s commercialization. Shares of Plus Therapeutics (PLTX) rose 5.7% following the announcement, trading at $18.30 as of 15:00 UTC on January 22, 2026.

Freeport-McMoRan Inc. will host its fourth-quarter 2025 earnings conference call on Wednesday, January 22, 2026, at 10:00 AM Eastern Time. The call follows the release of the company’s financial results for the period ended December 31, 2025, and will include commentary from executive leadership on operational performance, copper production, and guidance for 2026.

The mining company reported preliminary Q4 2025 copper production of 290 million pounds, in line with prior estimates. Full-year 2025 output reached 1.14 billion pounds, reflecting steady operations at key assets including Grasberg in Indonesia and Morenci in Arizona. Freeport-McMoRan’s shares traded at $48.75 per share as of market close on January 21, 2026, up 1.2% week-over-week. Investors are expected to focus on capital allocation plans, cost discipline, and potential divestitures amid a volatile metals market. The company also reiterated its long-term strategy to maintain a strong balance sheet while investing in sustainable mining practices.

Axogen Inc. shares fell 8.7% to $15.30 on January 22, 2026, following the company's announcement of a upsized underwritten public offering priced at $16.00 per share. The offering raised $124 million through the sale of 7.75 million new shares, increasing from an initial plan of $90 million. The move comes amid ongoing clinical development for its nerve repair products, including AxoGen’s Avance Nerve Graft.

The stock declined after market open, reflecting investor concern over dilution and near-term cash needs. Axogen stated the proceeds will fund research, commercial activities, and general corporate purposes. The offering was led by Jefferies and Cowen, with no existing shareholders participating in the placement. The company’s market capitalization stands at approximately $680 million as of January 22, 2026. Trading volume surged to 2.1 million shares, more than triple the 30-day average.

Initial jobless claims in the United States rose to 200,000 for the week ended January 19, 2026, a modest increase from the prior week’s revised figure of 198,000, according to data released by the Labor Department on Tuesday. The reading fell short of market expectations of 205,000, signaling continued strength in the labor market amid persistent inflation concerns.

The four-week moving average of claims climbed to 199,000, up slightly from 197,500 the previous week, reflecting steady employment conditions. Despite the uptick, claims remain near historic lows, supporting the view that the labor market remains resilient. The continued low level of unemployment claims may influence the Federal Reserve’s monetary policy decisions, as officials assess whether to maintain current interest rates or consider further tightening. The data adds to recent evidence of a tight labor market, with the unemployment rate holding at 3.8% in December 2025.

BlackRock CEO Larry Fink said on January 22, 2026, that there is no bubble in the artificial intelligence sector, emphasizing that developing AI requires massive investment. Speaking to Bloomberg at the World Economic Forum in Davos, Fink expressed full confidence in AI’s long-term potential and dismissed concerns of market overvaluation.

Fink, co-chair of this year’s forum, stated that trillions of dollars invested in AI will fuel global economic growth, despite inevitable setbacks. He noted that while some investors are reallocating away from U.S. dollar assets—about 5% have shifted due to prior overexposure—he does not expect further large-scale moves given the strength of the U.S. economy. The remarks come amid broad equity gains in 2025 and heightened interest in AI-driven innovation.

Wall Street analysts upgraded Alphabet Inc. (GOOGL) and initiated coverage on Micron Technology Inc. (MU) in major research calls released on January 22, 2026, signaling renewed investor interest in technology and semiconductor stocks. The moves reflect bullish sentiment amid strong earnings momentum and strategic positioning in AI-driven demand.

The upgrades come after Alphabet reported robust ad revenue growth and expanded cloud margins, prompting several firms to raise their price targets. Meanwhile, Micron received a buy rating from multiple analysts citing improved memory pricing and increased data center adoption. These calls are part of broader market reassessment following Q4 earnings season, with tech and semiconductors outperforming other sectors. Other notable actions include downgrades on select consumer discretionary names due to inflationary pressures. The updates are expected to influence portfolio allocations ahead of the February earnings cycle.

U.S. equities rose sharply at open on January 22, 2026, as easing tariff threats from President Trump toward Europe and Greenland reduced geopolitical tensions, while resilient economic data reinforced expectations of stable growth. The rally was supported by continued strength in AI and semiconductor stocks, with the Nasdaq and S&P 500 gaining over 0.9% and 0.7%, respectively.

The Dow Jones Industrial Average climbed 450.81 points to 49,528.04, the Nasdaq Composite rose 211.12 points to 23,435.94, and the S&P 500 gained 49.57 points to 6,925.19. The Philadelphia Semiconductor Index advanced 1.1% to 8,130.21, and TSMC ADRs jumped 2.07% to $332.93. Nvidia (NVDA-US) shares rose 0.7% after CEO Jensen Huang confirmed it has become TSMC’s largest customer, underscoring AI-driven demand. Alibaba (BABA-US) surged 4.79% amid reports of a potential IPO for its T-Head chip unit. Meanwhile, U.S. 10-year Treasury yields rose 2 basis points to 4.26%, and the dollar index edged down to 99.185. Key data showed Q3 real GDP revised up to 4.4% annualized, and initial jobless claims held steady at 200,000.

Texas Capital Bancshares Inc. (TCBI) reported fourth-quarter net income of $87.3 million, or $1.72 per diluted share, on January 22, 2026, exceeding analyst consensus of $1.58. The results represent an 18% increase from $74.1 million in Q4 2024.

Total revenue climbed 12% to $295.6 million, driven by a 9% expansion in net interest income to $242.3 million. The bank's net interest margin improved 15 basis points to 3.45%. Average loans held for investment grew 7% year-over-year to $18.2 billion.

Shares gained 4.2% to $65.30 in morning trading following the release. CEO Rob Holmes cited "disciplined expense management and strong credit quality" as key factors, with non-performing assets holding steady at 0.32% of total assets.

Ray Dalio, founder of Bridgewater Associates, said January 22, 2026, that global central banks are accelerating diversification away from US assets, driving gold prices up 67% as they seek alternatives to fiat currencies, particularly the dollar.

The hedge fund veteran highlighted a brewing "capital war," warning that military actions would have severe market implications. Danish pension fund AkademikerPension plans to exit US Treasuries by January 31, citing credit risks, while UBS Group AG (UBS) CEO Sergio Ermotti called weaponizing US debt holdings a "dangerous bet."

Dalio's comments follow US President Donald Trump's threats to acquire Greenland, which have intensified transatlantic tensions. The 76-year-old investor, who fully exited Bridgewater last year, spoke at the Davos forum.

Beazley (BEZ) unanimously rejected Zurich's (ZURN) £7.7 billion takeover offer on January 22, 2026, calling the 1,280p-per-share bid a material undervaluation. The FTSE 100 insurer disclosed it received three higher proposals in June 2025, including one at £8.4 billion.

Shares fell 3.6% to 1,083p, below the offer price, after jumping 40% to 1,140p on January 19 when Zurich disclosed its bid. Zurich CEO Mario Greco denied the approach was hostile, claiming transparency would encourage engagement. A merger would create a $15 billion revenue giant. Beazley reported $2.5 billion in shareholder returns over the past decade, including $1.3 billion in the last three years.